Skip to main content
MedPathMedPath Home
Clinical Trials/NCT01453244
NCT01453244
Completed
Not Applicable

Pharmacogenomic Research for Prediction of Drug Response in Korean Patients With Hepatitis C

Inje University1 site in 1 country373 target enrollmentJuly 2011
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsChronic Hepatitis C

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Hepatitis C
Sponsor
Inje University
Enrollment
373
Locations
1
Primary Endpoint
Sustained virological response (SVR)
Status
Completed
Last Updated
12 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The aim of this study is to investigate the relationships between drug response and the host genetic factors, viral factors and clinical factors in chronic hepatitis C patients (HCV). And thus, the investigators are trying to develop the pharmacogenomic guideline in the Korean patients with HCV.

Registry
clinicaltrials.gov
Start Date
July 2011
End Date
March 2013
Last Updated
12 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jae-Gook Shin

Jae-Gook Shin

Inje University

Eligibility Criteria

Inclusion Criteria

  • •Hepatitis C virus infected patients

Exclusion Criteria

  • •Patients who infected Hepatitis B virus or Human immunodeficiency virus
  • •HCV infected patients previously treated with antiviral drugs
  • •Patients had a history of autoimmune hemolytic anemia

Outcomes

Primary Outcomes

Sustained virological response (SVR)

Time Frame: 24 weeks after the end of treatment

Undetectable HCV RNA in serum ( \<15 IU/ml ) 24 weeks after the end of treatment

Secondary Outcomes

  • Anemia(4 weeks after start of treatment)

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Pharmacogenomic Study Realized on "Non-small Cell Lung Carcinoma"Carcinoma, Non-Small-Cell Lung
NCT00222404University Hospital, Grenoble556
Completed
Not Applicable
The Implementation of Pharmacogenomics Into Primary Care in British ColumbiaPharmacogenetics
NCT02383290University of British Columbia190
Completed
Not Applicable
Pharmacogenetic and Pharmacokinetic Study of ClopidogrelCoronary Artery Disease
NCT01968499The First Affiliated Hospital with Nanjing Medical University1,805
Completed
Not Applicable
Pharmacogenetic Variation: Factors That May Affect the Efficacy and Safety of Medical MarijuanaNew York Medical Marijuana Program Qualifying Conditions
NCT04083261Columbia Care Inc.157
Completed
Not Applicable
Pharmacogenetics of Warfarin Induction and InhibitionHealthy
NCT01447511University of Minnesota39